4.4 Review

A meta-analysis comparing simultaneous versus delayed resections in patients with synchronous colorectal liver metastases

Journal

SURGICAL ONCOLOGY-OXFORD
Volume 22, Issue 1, Pages 36-47

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.suronc.2012.11.002

Keywords

Synchronous colorectal liver metastases; Simultaneous resections; Colorectal cancer; Liver metastases; Hepatic metastases; Delayed resections

Funding

  1. National Institute for Health Research [NF-SI-0507-10161] Funding Source: researchfish

Ask authors/readers for more resources

Introduction: The traditional surgical management for patients presenting with synchronous colorectal liver metastases (SCLM) has been a delayed resection. However, in some centres, there has been a shift in favour of 'simultaneous' resections. The aim of this study was to use a meta-analytical model to compare the short-term and long-term outcomes in patients with synchronous colorectal liver metastases (SCLM) undergoing simultaneous resections versus delayed resections. Method: Comparative studies published between 1991 and 2010 were included. Evaluated endpoints were intra-operative parameters, post-operative parameters, post-operative adverse events and survival. A random-effects meta-analytical model was used and sensitivity analysis performed to account for bias in patient selection. Results: Twenty-four non-randomized studies were included, reporting on 3159 patients of which 1381 (43.7%) had simultaneous resections and 1778 (56.3%) had delayed resections. The bilobar distribution (P = 0.01), size of liver metastases (P < 0.001) and the proportion of major liver resections (P < 0.001) was found to be higher in the delayed resection group compared to the simultaneous resection group. There was no significant difference in operative blood loss (95% CI, -279.28, 22.53; P = 0.1) or duration of surgery (WMD -23.83, 95% CI, -85.04, 37.38; P = 0.45). Duration of hospital stay was significantly reduced in simultaneous resections by 5.6 days (95% CI: 2.4-8.9 days, P = 0.007) No significant differences in post-operative complications (36% vs 37%, P = 0.27), overall survival (HR 1.00, 95% CI 0.86 -1.15, P = 0.96) or disease free survival (HR 0.85, 95% CI 0.71-1.02, P = 0.08) were found. Sensitivity analysis revealed that these findings were consistent for the duration of hospital stay, post-operative complications, overall survival and disease free survival. Conclusion: This study demonstrates that the selection criteria for patients undergoing simultaneous or delayed resections differs resulting in a discrepancy in the metastatic disease severity being compared between the two groups. The comparable intra-operative parameters, post-operative complications and survival found between the two groups suggest that delayed resections may result in better outcomes. Similarly, the reduced length of hospital stay in simultaneous resections may only be as a result of the reduced disease severity in this group. Simultaneous resections can only be recommended in patients with limited hepatic disease until prospective studies comparing similar disease burdens between the two resection groups are available. (C) 2012 Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Lipidomic Profiling of Colorectal Lesions for Real-Time Tissue Recognition and Risk-Stratification Using Rapid Evaporative Ionization Mass Spectrometry

Sam E. Mason, Eftychios Manoli, James L. Alexander, Liam Poynter, Lauren Ford, Petra Paizs, Afeez Adebesin, James S. McKenzie, Francesca Rosini, Rob Goldin, Ara Darzi, Zoltan Takats, James M. Kinross

Summary: This study used REIMS to analyze the lipid composition of colorectal tissues and evaluate its accuracy for real-time tissue recognition and risk stratification. The results showed that REIMS can differentiate samples of carcinoma, adenoma, and normal mucosa with 93.1% accuracy and 96.1% negative predictive value for carcinoma. It can also predict the presence of neoplasia (carcinoma or adenoma) with 96.0% accuracy and 91.8% negative predictive value. In addition, the study identified unique lipidomic features associated with colorectal carcinogenesis, such as the progressive increase in relative abundance of phosphatidylglycerols, sphingomyelins, and monounsaturated fatty acid-containing phospholipids.

ANNALS OF SURGERY (2023)

Review Surgery

Systematic review and meta-analysis comparing perioperative outcomes of emergency appendectomy performed by trainee vs trained surgeon

Theophilus T. K. Anyomih, Thomas Jennings, Alok Mehta, J. Robert O'Neill, Ioanna Panagiotopoulou, Stavros Gourgiotis, Elizabeth Tweedle, John Bennett, R. Justin Davies, Constantinos Simillis

Summary: A systematic literature review and meta-analysis comparing outcomes of appendectomy performed by trainees versus trained surgeons found no difference in patient safety and perioperative outcomes. Trainees had longer operating time, but shorter duration of hospital stay and decreased reoperation rate.

AMERICAN JOURNAL OF SURGERY (2023)

Review Gastroenterology & Hepatology

Operative blood loss adversely affects short and long-term outcomes after colorectal cancer surgery: results of a systematic review and meta-analysis

C. Simillis, M. Charalambides, A. Mavrou, T. Afxentiou, M. P. Powar, J. Wheeler, R. J. Davies, N. S. Fearnhead

Summary: Operative blood loss has a significant impact on short-term and long-term outcomes following colorectal cancer surgery. Increased blood loss is associated with higher morbidity, anastomotic leak, postoperative ileus, surgical site infections, and prolonged hospital stay. It is also associated with worse overall survival, recurrence-free survival, and small bowel obstruction caused by colorectal cancer recurrence. Measures should be taken to minimize operative blood loss during colorectal cancer surgery.

TECHNIQUES IN COLOPROCTOLOGY (2023)

Article Pathology

Survey of liver pathologists to assess attitudes towards digital pathology and artificial intelligence

Clare McGenity, Rebecca Randell, Christopher Bellamy, Alastair Burt, Alyn Cratchley, Robert Goldin, Stefan G. Hubscher, Desley A. H. Neil, Alberto Quaglia, Dina Tiniakos, Judy Wyatt, Darren Treanor

Summary: This study surveyed members of the UK Liver Pathology Group to understand their attitudes and priorities towards digital pathology and artificial intelligence in liver disease. The majority of liver pathologists in the UK are in favor of using digital pathology and AI in clinical practice, research, and education.

JOURNAL OF CLINICAL PATHOLOGY (2023)

Article Cell Biology

Regulation of immunological tolerance by the p53-inhibitor iASPP

Elliot H. H. Akama-Garren, Paul Miller, Thomas M. M. Carroll, Michael Tellier, Gopinath Sutendra, Ludovico Buti, Justyna Zaborowska, Robert D. D. Goldin, Elizabeth Slee, Francis G. G. Szele, Shona Murphy, Xin Lu

Summary: Maintaining a balance between tolerance and autoimmunity is crucial for preventing human diseases. The protein p53 and its regulator iASPP play important roles in immunological tolerance and tumorigenesis. Deficiency in iASPP promotes tumor development but reduces susceptibility to autoimmune diseases. Furthermore, iASPP-deficient tumors exhibit immunosuppression characteristics, suggesting potential therapeutic opportunities for targeting the iASPP/p53 axis in autoimmune diseases and cancer.

CELL DEATH & DISEASE (2023)

Article Gastroenterology & Hepatology

Rationalising the use of specimen pots following colorectal polypectomy: a small step towards greener endoscopy

Karl King Yong, Yun He, Hoi Ching Annie Cheung, Ramya Sriskandarajah, William Jenkins, Robert Goldin, Sabina Beg

Summary: This study aimed to determine if combining multiple small colorectal polyps in a single specimen pot can reduce carbon footprint without negatively impacting clinical outcomes. Results showed that consolidating small polyps could decrease carbon footprint, but may also result in missing advanced lesions. Therefore, changing practice at a national level could amplify the reduction in carbon footprint from judicious use of specimen pots.

FRONTLINE GASTROENTEROLOGY (2023)

Article Biochemistry & Molecular Biology

p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer

Paul Miller, Elliot H. Akama-Garren, Richard P. Owen, Constantinos Demetriou, Thomas M. Carroll, Elizabeth Slee, Khatoun Al Moussawi, Michael Ellis, Robert Goldin, Eric O'Neill, Xin Lu

Summary: iASPP is an inhibitor of p53 that suppresses inflammation and oncogenic KRAS-driven pancreatic cancer tumorigenesis.

CELL DEATH AND DIFFERENTIATION (2023)

Review Oncology

A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer

Constantinos Simillis, Amulya Khatri, Nick Dai, Thalia Afxentiou, Catherine Jephcott, Sarah Smith, Rashmi Jadon, Demetris Papamichael, Jim Khan, Michael P. Powar, Nicola S. Fearnhead, James Wheeler, Justin Davies

Summary: This systematic literature review investigated and compared the neoadjuvant therapy strategies for stage II and III rectal cancer. The study found that conventional neoadjuvant therapies with short-course radiation or long-course chemoradiotherapy have oncological benefits without increasing perioperative complication rates. Prolonged wait to surgery may improve oncological outcomes. Total neoadjuvant therapies provide additional benefits in terms of complete response, positive resection margins, and disease-free survival. Monoclonal antibody therapy may further improve oncological outcomes but currently is only applicable to a small subgroup of patients and requires further validation.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2023)

Article Biochemistry & Molecular Biology

Metabolic Profile Reflects Stages of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease

Nila Jambulingam, Roberta Forlano, Benjamin Preston, Benjamin H. Mullish, Greta Portone, Yama Baheer, Michael Yee, Robert D. Goldin, Mark R. Thursz, Pinelopi Manousou

Summary: Nonalcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease worldwide, and fibrosis stage is an important predictor for clinical outcomes. This study investigates the metabolic profile of NAFLD patients in relation to fibrosis progression. The results show that a combination of metabolites and lipoproteins can accurately identify fast fibrosis progressors and perform better than noninvasive markers. These specific metabolic profiles can predict fibrosis progression in patients with NAFLD, and algorithms combining metabolites and lipids could be used for risk stratification of these patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Gastroenterology & Hepatology

Sleeve gastrectomy causes weight-loss independent improvements in hepatic steatosis

Emma Rose McGlone, Matthieu Siebert, Marian Dore, David C. D. Hope, Iona Davies, Bryn Owen, Bernard Khoo, Rob Goldin, Dave Carling, Stephen Bloom, Maude Le Gall, Tricia M-M. Tan

Summary: The study investigated the effects of sleeve gastrectomy on weight-independent improvements in liver steatosis in mice with diet-induced obesity. It was found that VSG not only improves liver fat content but also enhances insulin and glucagon sensitivity.

LIVER INTERNATIONAL (2023)

Article Gastroenterology & Hepatology

Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

Diego Calvisi, Luke Boulter, Javier Vaquero, Anna Saborowski, Luca M. Fabris, Pedro Rodrigues, Cedric E. Coulouarn, Rui Castro, Oreste Segatto, Chiara Raggi, Luc J. W. van der Laan, Guido Carpino, Benjamin Goeppert, Stephanie J. Roessler, Timothy Kendall, Matthias Evert, Ester W. Gonzalez-Sanchez, Juan Valle, Arndt Vogel, John J. Bridgewater, Mitesh J. Borad, Gregory R. Gores, Lewis Roberts, Jose J. G. B. Marin, Jesper Andersen, Domenico Alvaro, Alejandro M. Forner, Jesus Banales, Vincenzo Cardinale, Rocio I. R. Macias, Silve Vicent, Xin Chen, Chiara Braconi, Monique M. A. Verstegen, Laura Fouassier, Lewis Roberts, Alexander Scheiter, Florin M. Selaru, Katja Evert, Kirsten Utpatel, Laura Broutier, Massimiliano Cadamuro, Meritxell Huch, Robert Goldin, Sergio A. Gradilone, Yoshimasa Saito

Summary: In this Consensus Statement, experts provide recommendations on the criteria for preclinical models of cholangiocarcinoma (CCA) to increase disease understanding and develop novel therapeutic approaches.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)

Article Multidisciplinary Sciences

Immune checkpoint inhibitor-induced colitis is mediated by polyfunctional lymphocytes and is dependent on an IL23/IFNγ axis

Jonathan W. Lo, Domenico Cozzetto, James L. Alexander, Nathan P. Danckert, Matthew Madgwick, Naomi Knox, Jillian Yong Xin Sieh, Marton Olbei, Zhigang Liu, Hajir Ibraheim, Jesus Miguens Blanco, Hiromi Kudo, Rocio Castro Seoane, Lucia A. Possamai, Robert Goldin, Julian Marchesi, Tamas Korcsmaros, Graham M. Lord, Nick Powell

Summary: Immune checkpoint inhibitors (CPIs) are a new cancer treatment that can potentially cure previously untreatable diseases. However, they can also cause off-target immune-mediated tissue injury. Researchers found that CPI-colitis in mice depends on the composition of the intestinal microbiota and the expression of certain immune molecules. Targeting these factors may hold the key to reversing CPI-colitis.

NATURE COMMUNICATIONS (2023)

Article Gastroenterology & Hepatology

Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma

David J. Pinato, Takahiro Kaneko, Antonio D'Alessio, Alejandro Forner, Petros Fessas, Beatriz Minguez, Edoardo G. Giannini, Federica Grillo, Alba Diaz, Francesco A. Mauri, Claudia A. M. Fulgenzi, Alessia Dalla Pria, Robert D. Goldin, Giulia Pieri, Pierluigi Toniutto, Claudio Avellini, Maria Corina Plaz Torres, Ayse U. Akarca, Teresa Marafioti, Sherrie Bhoori, Jose Maria Miro, Mark Bower, Norbert Brau, Vincenzo Mazzaferro

Summary: The aim of this study was to evaluate the impact of HIV infection on the functional characteristics of T cell infiltrate in hepatocellular carcinoma (HCC). Results showed that HIV infection was associated with increased immune exhaustion and higher expression of PD-L1 in tumor tissue. Therefore, prospective testing of immunotherapy in HIV-associated HCC is warranted.

JHEP REPORTS (2023)

Meeting Abstract Gastroenterology & Hepatology

IMMUNE CHECKPOINT INHIBITOR-INDUCED COLITIS IS MEDIATED BY CYTOTOXIC LYMPHOCYTES AND IS RELIANT ON THE IL23/IFNγ AXIS

Jonathan W. Lo, Domenico Cozzetto, Matthew Madgwick, Jillian Y. Sieh, Marton Olbei, James L. Alexander, Jesus Miguens Blanco, Hiromi Kudo, Hajir Ibraheim, Zhigang Liu, Rocio Castro Seoane, Robert Goldin, Julian Marchesi, Tamas Korcsmaros, Graham Lord, Nick Powell

GASTROENTEROLOGY (2022)

Meeting Abstract Gastroenterology & Hepatology

Il-1beta Signal Inhibition in acute alcoholic hepatitis: a multicentre, randomised, double-blind, placebo-controlled phase 2 trial of canakinumab therapy (ISAIAH)

Nikhil Vergis, Vishal C. Patel, Karolina Bogdanowicz, Justyna Czyzewska-Khan, Rosemary Keshinro, Francesca Fiorentino, Emily Day, Paul Middleton, Stephen Atkinson, Mary Cross, Daphne Babalis, Neil Foster, Alberto Quaglia, Josephine Lloyd, Robert D. Goldin, William Rosenberg, Richard Parker, Paul Richardson, Steven Masson, Gavin Whitehouse, Cyril Sieberhagen, David Patch, Ashwin Dhanda, Emma Lord, Ewan Forrest, Nikolai Naoumov, Mark Thursz

JOURNAL OF HEPATOLOGY (2022)

No Data Available